Polymorphism of the apolipoprotein A-IV gene and its significance in lipid metabolism and coronary heart disease in a Japanese population

European Journal of Clinical Investigation

Volumn 26, Issue 12, 1996, Pages 1115-1124

  Bai, H ^a   Saku, K ^a   Liu, R ^b   Oribe, Y ^b   Yamamoto, K ^c   Arakawa, K ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Department of Internal Medicine   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

Apolipoprotein A IV; Coronary heart disease; Genetic polymorphism; Japanese; Lipids; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A;

ADULT; ARTICLE; ATHEROSCLEROSIS; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; JAPAN; LIPID METABOLISM; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0030442312     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.430596.x     Document Type: Article

References (44)

1. Beisiegel U, Utermann G. An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma. Isolation and partial characterization. Eur J Biochem 1979;93:601-8.
2. Green PHR, Glickman RM, Saudek CD, Blum CB, Tall AR. Human intestinal lipoproteins: studies in chyluric subjects. J Clin Invest 1979;64:233-42.
3. Green PHR, Glickman RM, Riley JW, Quinet E. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 1980;65:911-9.
4. Lagrost L, Gambert P, Boquillon M, Lallemant C. Evidence for high density lipoproteins as the major apolipoprotein A-IV-containing fraction in normal human serum. J Lipid Res 1989; 30:1525-34.
5. Bisgaier CL, Glickman RM. Intestinal synthesis, secretion, and transport of lipoproteins. Annu Rev Physiol 1983;45:625-36.
6. Steinmetz A, Utermann G. Activation of lecithin: cholesterol acyltransferase by human lipoprotein A-IV. J Biol Chem 1985; 260:2258-64.
7. Barter PJ, Rajaram OV, Chang LBF et al. Isolation of high density lipoprotein conversion factor from human plasma: a possible role of apolipoprotein A-IV as its activator. Biochem J 1988;254:179-84.
8. Stein O, Stein Y, Lefevre M, Roheim PS. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim Biophys Acta 1986;878:7-13.
9. Fujimoto K, Fukagawa K, Sakata T, Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest 1993;91:1830-3.
10. Karathanasis SK, Oettgen P, Haddad IA, Antonarakis SE. Structure, evolution, and polymorphisms of the human apolipoprotein A4 gene (APOA4). Proc Natl Acad Sci USA 1986; 83:8457-61.
11. Elshourbagy NA, Walker DW, Paik Y-K et al. Structure and expression of the human apolipoprotein A-IV gene. J Biol Chem 1987;262:7973-81.
12. Menzel HJ, Kladetzky R, Assmann G. One-step screening method for the polymorphism of apolipoprotein A-I, A-II, and A-IV. J Lipid Res 1982;23:915-22.
13. Lohse P, Brewer HB Jr. Genetic polymorphism of apolipoprotein A-IV. Curr Opin Lipidol 1991;2:90-5.
14. Boerwinkle E, Visvikis S, Chan L. Two polymorphisms in amino acid substitutions in the apo A4 gene. Nucleic Acids Res 1990;18:4966.
15. Lohse P, Kindt MR, Rader DJ, Brewer HB Jr. Genetic polymorphism of human plasma apolipoprotein A-IV is due to nucleotide substitutions in the apolipoprotein A-IV gene. J Biol Chem 1990;265:10061-4.
16. Tenkanen H, Lukka M, Jauhiainen M et al. The mutation causing the common apolipoprotein A-IV polymorphism is a glutamine to histidine substitution of amino acid 360. Arteriosclerosis. 1991;11:851-6.
17. Lohse P, Kindt MR, Rader DJ, Brewer HB Jr. Human plasma apolipoproteins A-IV-0 and A-IV 3. Molecular basis for two rare variants of apolipoprotein A-IV-1. J Biol Chem 1990; 265:12734-9.
18. Lohse P, Kindt MR, Rader DJ, Brewer HB Jr. Three genetic variants of human plasma apolipoprotein A-IV: Apo A-IV-1 (Thr347Ser), apo A-IV-0 (Lys167Gln) (Gln360His) and apoA-IV-3 (Glu165Lys). J Biol Chem 1991;266:13513-7.
19. Von Eckardstein A, Funke H, Schulte M, Erren M, Schulte H, Assmann G. Nonsynonymous polymorphic sites in apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet 1992;50:1115-28.
20. Tenkanen H, Koskinen P, Metso J et al. A novel polymorphism of apolipoprotein A-IV is the result of an asparagine to serine substitution at residue 127. Biochim Biophys Acta 1992;1138: 27-33.
21. Ferrell RE, Sepehrnia A, Kamboh MI, Van De Berg JL. Highly polymorphic apolipoprotein A-IV locus in the baboon. J Lipid Res 1990;3:131-5.
22. Juneja RK, Gahne B, Lukka M, Ehnholm C. A previously reported polymorphic plasma protein of dogs and horses identified as apolipoprotein A-IV. Animal Genet 1989;20:59-63.
23. Allain CC, Poon LS, Chan CS. Enzymatic determination of total cholesterol. Clin Chem 1974;20:470-5.
24. Eggestein M, Kreuntz FH. Eine neue Bestimmung der Neutralfette in Blutserum und Gewebe I. MItt. Prinzip, Durchfuhrung und Besprechung der Methode. Klin Wochenschr 1966;44:262.
25. Noma A, Nezu-Nakayama K, Kita M, Okabe H. Simultaneous determination of serum cholesterol in high- and low-density lipoproteins with use of heparin Ca2+, and anion-exchange resin. Clin Chem 1978;24:1504-8.
26. Ikeda T, Shibuya U, Sugiushi H, Araki S, Uji Y, Okabe H. Automated immunoturbidimetric analysis of six plasma apolipoproteins: correlation with radial immunodiffusion assays. J Clin Lab Anal 1991;5:90-5.
27. Abe A, Maeda S, Makino K et al. Enzyme-linked immunosorbent assay of lipoprotein (a) in serum and cord blood. Clin Chim Acta 1988;177:31-40.
28. Kumar R, Barbacid M. Oncogene detection at the single cell level. Oncogene 1988;3:647-51.
29. Kumar R, Dunn L. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes. Oncogene Res 1989;1:235-41.
30. Bai H, Saku K, Liu R, Funke H, von Eckardstein A, Arakawa K. Polymorphic site study at codon 347 of apolipoprotein A-IV in a Japanese population. Biochim Biophys Acta 1993;1174:279-81.
31. Tenkanen H. Genotyping of apolipoprotein A-IV by digestion of amplified DNA with restriction endonuclease Fun4HI: use of a tailored primer to abolish additional recognition sites during the gene amplification. J Lipid Res 1991;30:545-9.
32. Paul-Hayase H, Rosseneu M, Robinson D, Van Bervliet JP, Deslypere JP, Humphries SE. Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Hum Genet 1992;88:439 46.
33. Williams RR. Understanding genetic and environmental risk factors in susceptible persons. West J Med 1984;141:799-806.
34. Humphries SE, Talmud PJ, Kessling AE. The use of DNA polymorphisms of the apolipoprotein genes to study the role of genetic variation in determination of serum lipid levels. Ciba Found Symp 1987;130:128-49.
35. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
36. Asakawa J, Takahashi N, Rosenblum BB, Neel JV. Two-dimensional gel studies of genetic variation in the plasma protein of Amerindians and Japanese. Hum Genet 1985;70:222-30.
37. Akiyama K. Population study of apolipoprotein A-IV polymorphism and report of a new variant in Japanese. Hum Hered 1989;39:302-4.
38. Kamboh MI, Ferrel RE. Genetic studies of human apolipoproteins: I. Polymorphism of apolipoprotein A-IV. Am J Hum Genet 1987;41:119-27.
39. de Knijff P, Johansen LG, Rosseneu M, Frants RR, Jespersen J, Havekes LM. Lipoprotein profile of a Greenland Inuit population: influence of anthropometric variables, apo E and A4 polymorphism, and lifestyle. Arterioscler Thromb 1992;12: 1371-9.
40. Von Eckardstein A, Funke H, Chirazi A et al. Sex-specific effects of the glutamine/histidine polymorphism in apo A-IV on HDL metabolism. Arterioscler Thromb 1994;14:1114-20.
41. Ehnholm C, Tenkanen H, de Knijff P et al. on behalf of the EARS Group. Genetic polymorphism of apolipoprotein A-IV in five different regions of Europe. Relations to plasma lipoproteins and to history of myocardial infarction: the EARS study. Atherosclerosis 1994;107:229-38.
42. Weinberg RB, Dantzker C, Patton CS. Sensitivity of serum apolipoprotein A-IV levels to changes in dietary fat content. Gastroenterology 1990;98:17-24.
43. Aalto-Setala K, Bisgaier CL, Ho A et al. Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. J Clin Invest 1994; 93:1776-86.
44. Goto Y. Hyperlipidemia and atherosclerosis in Japan. Atherosclerosis 1980;36:341-9.